These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28152063)

  • 1. A wavelet-based technique to predict treatment outcome for Major Depressive Disorder.
    Mumtaz W; Xia L; Mohd Yasin MA; Azhar Ali SS; Malik AS
    PLoS One; 2017; 12(2):e0171409. PubMed ID: 28152063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI.
    Ma H; Zhang D; Wang Y; Ding Y; Yang J; Li K
    BMC Psychiatry; 2023 Jun; 23(1):466. PubMed ID: 37365541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A machine learning approach using EEG data to predict response to SSRI treatment for major depressive disorder.
    Khodayari-Rostamabad A; Reilly JP; Hasey GM; de Bruin H; Maccrimmon DJ
    Clin Neurophysiol; 2013 Oct; 124(10):1975-85. PubMed ID: 23684127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A major depressive disorder classification framework based on EEG signals using statistical, spectral, wavelet, functional connectivity, and nonlinear analysis.
    Movahed RA; Jahromi GP; Shahyad S; Meftahi GH
    J Neurosci Methods; 2021 Jul; 358():109209. PubMed ID: 33957158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EEG microstates as markers of major depressive disorder and predictors of response to SSRIs therapy.
    Lei L; Liu Z; Zhang Y; Guo M; Liu P; Hu X; Yang C; Zhang A; Sun N; Wang Y; Zhang K
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jun; 116():110514. PubMed ID: 35085607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of treatment response in major depressive disorder using a hybrid of convolutional recurrent deep neural networks and effective connectivity based on EEG signal.
    Mirjebreili SM; Shalbaf R; Shalbaf A
    Phys Eng Sci Med; 2024 Jun; 47(2):633-642. PubMed ID: 38358619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective brain connectivity technique to predict repetitive transcranial magnetic stimulation outcome for major depressive disorder patients using EEG signals.
    Nobakhsh B; Shalbaf A; Rostami R; Kazemi R; Rezaei E; Shalbaf R
    Phys Eng Sci Med; 2023 Mar; 46(1):67-81. PubMed ID: 36445618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using pre-treatment EEG data to predict response to SSRI treatment for MDD.
    Khodayari-Rostamabad A; Reilly JP; Hasey G; Debruin H; Maccrimmon D
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():6103-6. PubMed ID: 21097134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An EEG-based functional connectivity measure for automatic detection of alcohol use disorder.
    Mumtaz W; Saad MNBM; Kamel N; Ali SSA; Malik AS
    Artif Intell Med; 2018 Jan; 84():79-89. PubMed ID: 29169647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal EEG predictors of treatment outcome in major depressive disorder.
    Iosifescu DV; Greenwald S; Devlin P; Mischoulon D; Denninger JW; Alpert JE; Fava M
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):772-7. PubMed ID: 19574030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of machine learning in predicting clinical response to transcranial magnetic stimulation in comorbid posttraumatic stress disorder and major depression: A resting state electroencephalography study.
    Zandvakili A; Philip NS; Jones SR; Tyrka AR; Greenberg BD; Carpenter LL
    J Affect Disord; 2019 Jun; 252():47-54. PubMed ID: 30978624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder.
    Leuchter AF; Hunter AM; Jain FA; Tartter M; Crump C; Cook IA
    J Psychiatr Res; 2017 Jan; 84():174-183. PubMed ID: 27770740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder.
    Iosifescu DV; Greenwald S; Devlin P; Perlis RH; Denninger JW; Alpert JE; Fava M
    Acta Psychiatr Scand; 2008 Apr; 117(4):271-6. PubMed ID: 18307587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning approaches and non-linear processing of extracted components in frontal region to predict rTMS treatment response in major depressive disorder.
    Ebrahimzadeh E; Fayaz F; Rajabion L; Seraji M; Aflaki F; Hammoud A; Taghizadeh Z; Asgarinejad M; Soltanian-Zadeh H
    Front Syst Neurosci; 2023; 17():919977. PubMed ID: 36968455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A major depressive disorder diagnosis approach based on EEG signals using dictionary learning and functional connectivity features.
    Movahed RA; Jahromi GP; Shahyad S; Meftahi GH
    Phys Eng Sci Med; 2022 Sep; 45(3):705-719. PubMed ID: 35635612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major depressive disorder assessment via enhanced k-nearest neighbor method and EEG signals.
    Saeedi M; Saeedi A; Maghsoudi A
    Phys Eng Sci Med; 2020 Sep; 43(3):1007-1018. PubMed ID: 32662038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2007 Jan; 17(1):32-6. PubMed ID: 16762534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A machine learning framework involving EEG-based functional connectivity to diagnose major depressive disorder (MDD).
    Mumtaz W; Ali SSA; Yasin MAM; Malik AS
    Med Biol Eng Comput; 2018 Feb; 56(2):233-246. PubMed ID: 28702811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.